Skip to main content

Please note: this event has passed

Register your place for this Inaugural Lecture on Microsoft Forms.

Join us to celebrate a special milestone for our new professors and hear about their inspiring career journeys. Doors for this event will open on 16.45 (BST), with the lectures to commence at 16.50. A drinks reception will be held at 18.00 immediately after the lecture.

Professor James Galloway

Thoughts on becoming a rheumatic diseases epidemiologist


James will review his journey to becoming a clinical epidemiologist in rheumatology, sharing how his clinical and academic experiences have entwined. He will share how the astonishing evolution of treatments for autoimmune diseases like rheumatoid arthritis has been accompanied by enormous challenges in learning how we can study drug safety.


James Galloway graduated from medical school in 2001 from the University of Bristol. He undertook training as a physician in the North West, and subspecialised in Rheumatology. He did a PhD with what was then the Arthritis Research UK Epidemiology Unit, studying pharmacovigilance. He was appointed to a Clinical Lecturer post at King's College London in 2012, where he further developed his research in clinical epidemiology in rheumatic diseases. 

Professor Anita Grigoriadis

From bioinformatics to digital pathology, mapping a journey through translational breast cancer research


In this lecture, I will describe my career as a breast cancer bioinformatician. After my maternity leave, I returned to research, entering the relatively unknown field of bioinformatics with great expectations. This research area rapidly exploded and the demand for computer scientists who understand the clinical and experimental aspects increased exponentially. This call for a multidisciplinary skillset led me to not only drive explorative research in breast cancer but also to many drug-discovery and biomarker studies, as well as the involvement in key clinical trials. With new technologies constantly necessitating novel analytical approaches, spatial and digital pathology have recently become our latest challenge. I keep being inspired by how discovering translational biomarkers impacts patient care.


Anita Grigoriadis is a Professor of Molecular and Digital Pathology in Cancer Bioinformatics and leads the Cancer Bioinformatics group in the School of Cancer and Pharmaceutical Sciences. Her research explores molecular and morphological determinants reflective of local and systemic immune responses in triple-negative breast cancer patients. After finishing her degree at the Institute of Molecular Pathology, University of Vienna (Austria), Anita pursued a joint PhD between the Ludwig Institute for Cancer Research, London, UK and the Faculty of Natural Sciences (Salzburg, Austria). Anita conducted her postdoctoral training on breast cancer genomics with Professor Alan Ashworth at Breakthrough Breast Cancer Centre (London). In 2008, she joined the Breast Cancer NOW Unit (formerly Breakthrough Breast Cancer Research) at King’s under the leadership of Professor Andrew Tutt and started her team in 2013.

At this event